McNeil to launch Nicotrol NS nicotine nasal spray in July, following March 22 approval.
This article was originally published in The Tan Sheet
Executive Summary
McNEIL TO LAUNCH NICOTROL NS NICOTINE NASAL SPRAY IN JULY in conjunction with the "Pathways to Change" behavior modification program. Nicotrol NS prescription nicotine nasal spray (NDA 20-385) was approved by FDA on March 22 as an aid to smoking cessation. Under license from Pharmacia & Upjohn, the drug is indicated as an "aid to smoking cessation for the relief of nicotine withdrawal symptoms" and "should be used as part of a comprehensive behavioral smoking cessation program," labeling states. Pharmacia & Upjohn filed an NDA for the nicotine nasal spray on July 30, 1993.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning